These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1979459)

  • 21. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
    Sanders KH; Beller KD; Kolassa N
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S86-93. PubMed ID: 1702492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT3 receptor-active drugs alter development of spinal serotonergic innervation: lack of effect of other serotonergic agents.
    Bell J; Zhang XN; Whitaker-Azmitia PM
    Brain Res; 1992 Feb; 571(2):293-7. PubMed ID: 1535269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML; Schenck KW; Hemrick-Luecke SH
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats.
    Ramage AG; Fozard JR
    Eur J Pharmacol; 1987 Jun; 138(2):179-91. PubMed ID: 2957220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
    Doods HN; Boddeke HW; Kalkman HO; Hoyer D; Mathy MJ; van Zwieten PA
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory presynaptic 5-hydroxytryptamine (5-HT) receptors on the sympathetic nerves of the human saphenous vein.
    Göthert M; Kollecker P; Rohm N; Zerkowski HR
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):317-23. PubMed ID: 2942782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Van den Buuse M
    Eur J Pharmacol; 1992 Nov; 223(2-3):133-41. PubMed ID: 1362161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
    Deckert V; Chaouloff F; Richer C; Elghozi JL
    Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The functional significance of neonatal 5,7-dihydroxytryptamine lesions in the rat: response to selective 5-HT1A and 5-HT2,1C agonists.
    Pranzatelli MR; Dollison AM; Huang YY
    Brain Res Bull; 1990 Jun; 24(6):747-53. PubMed ID: 2142615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmission.
    Claustre Y; Rouquier L; Serrano A; Bénavidès J; Scatton B
    Eur J Pharmacol; 1991 Oct; 204(1):71-7. PubMed ID: 1666563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and neurochemical effects of the serotonin (5-HT)1A receptor ligand spiroxatrine.
    Barrett JE; Hoffmann SM; Olmstead SN; Foust MJ; Harrod C; Weissman BA
    Psychopharmacology (Berl); 1989; 97(3):319-25. PubMed ID: 2524083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity.
    McCall RB; Patel BN; Harris LT
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1152-9. PubMed ID: 2958619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are drugs that act both on serotonin receptors and alpha 1-adrenoceptors more potent hypotensive agents than those that act only on alpha 1-adrenoceptors?
    Ramage AG
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S30-4. PubMed ID: 2459511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desensitization of spinal 5-HT1A receptors to 8-OH-DPAT: an in vivo spinal reflex study.
    Seth P; Gajendiran M; Ganguly DK
    Neuroreport; 1997 Jul; 8(11):2489-93. PubMed ID: 9261814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal cord serotonin receptors in cardiovascular regulation and potentiation of the pressor response to intrathecal substance P after serotonin depletion.
    Hasséssian H; Poulat P; Hamel E; Reader TA; Couture R
    Can J Physiol Pharmacol; 1993 Jul; 71(7):453-64. PubMed ID: 7694781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
    Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypotensive effects of 5-HT1A receptor agonists on the ventrolateral medullary pressor area in dogs.
    Dabiré H; Laubie M; Schmitt H
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S61-7. PubMed ID: 1702488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation.
    Prow MR; Martin KF; Heal DJ
    Eur J Pharmacol; 1996 Dec; 317(1):21-8. PubMed ID: 8982715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presynaptic autoinhibition of central noradrenaline release in vitro: operational characteristics and effects of drugs acting at alpha-2 adrenoceptors in the presence of uptake inhibition.
    Valenta B; Drobny H; Singer EA
    J Pharmacol Exp Ther; 1988 Jun; 245(3):944-9. PubMed ID: 2838608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.